ADA's William T. Cefalu, MD, to Testify Before U.S. Senate's Special Committee on Aging Regarding the Rising Cost of Insulin
ARLINGTON, Va., May 2, 2018 /PRNewswire-USNewswire/ --The American Diabetes Association's (ADA's) Chief Scientific, Medical and Mission Officer William T. Cefalu, MD, will testify before the U.S. Senate's Special Committee on Aging (Committee) at 10:00 a.m.
- ARLINGTON, Va., May 2, 2018 /PRNewswire-USNewswire/ --The American Diabetes Association's (ADA's) Chief Scientific, Medical and Mission Officer William T. Cefalu, MD, will testify before the U.S. Senate's Special Committee on Aging (Committee) at 10:00 a.m.
- Dr. Cefalu will address the Committee about the rising costs of insulin, which impact millions of Americans with diabetes who rely on this life-sustaining medication.
- He will also share the findings of the ADA's " Insulin Access and Affordability Working Group: Conclusions and Recommendations " white paper, which will be simultaneously published in the journal Diabetes Care.
- Senate Special Committee on Aging:
What:Dr. Cefalu will highlight the key findings of the ADA's Insulin Access and Affordability Working Group (Working Group), as detailed in the " Insulin Access and Affordability Working Group: Conclusions and Recommendations " white paper.